Mirapex ER approved for advanced Parkinson's

Share this content:
Mirapex ER approved for advanced Parkinson's
Mirapex ER approved for advanced Parkinson's
The FDA has approved Mirapex ER for the signs and symptoms of advanced idiopathic Parkinson's disease. In a recent trial, the drug outperformed a placebo over an 18-week span, according to the manufacturer.
http://us.boehringer-ingelheim.com/